• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

齐多夫定成功治疗与HIV相关的严重血小板减少症。持续缓解报告。

Successful zidovudine therapy for HIV-related severe thrombocytopenia. Report of a sustained remission.

作者信息

Peña J M, Arnalich F, Barbado F J, Dominguez A, Mostaza J, Valencia M E, Vazquez J J

机构信息

Department of Internal Medicine, Faculty of Medicine, Hospital La Paz, Madrid, Spain.

出版信息

Acta Haematol. 1990;83(2):86-8. doi: 10.1159/000205174.

DOI:10.1159/000205174
PMID:2106201
Abstract

Five patients, two homosexuals and three drug abusers, with HIV-related severe thrombocytopenia, four of whom had also bleeding episodes, experienced a full remission of thrombocytopenia after 1,200 mg/day zidovudine treatment. None of the patients had acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. Platelet counts began an upward trend at the end of the 3rd week and reached values higher than 140 x 10(9)/l towards the end of the 8th week of treatment. Patient's platelets remained stable after more than 4 months of active treatment. This is the first report of zidovudine-induced long-term remission of HIV-associated severe thrombocytopenia.

摘要

五名患者,其中两名同性恋者和三名药物滥用者,患有与HIV相关的严重血小板减少症,其中四人还出现过出血发作,在接受每日1200毫克齐多夫定治疗后血小板减少症完全缓解。这些患者均未患有获得性免疫缺陷综合征(AIDS)或AIDS相关综合征。血小板计数在第3周结束时开始呈上升趋势,在治疗第8周结束时达到高于140×10⁹/L的值。经过4个多月的积极治疗后,患者的血小板保持稳定。这是齐多夫定诱导HIV相关严重血小板减少症长期缓解的首例报告。

相似文献

1
Successful zidovudine therapy for HIV-related severe thrombocytopenia. Report of a sustained remission.齐多夫定成功治疗与HIV相关的严重血小板减少症。持续缓解报告。
Acta Haematol. 1990;83(2):86-8. doi: 10.1159/000205174.
2
The long-term use of zidovudine in patients with severe immune-mediated thrombocytopenia secondary to infection with HIV.齐多夫定在继发于HIV感染的严重免疫介导性血小板减少症患者中的长期应用。
AIDS. 1991 Nov;5(11):1357-61. doi: 10.1097/00002030-199111000-00012.
3
Zidovudine for thrombocytopenic purpura related to human immunodeficiency virus (HIV) infection.齐多夫定用于治疗与人类免疫缺陷病毒(HIV)感染相关的血小板减少性紫癜。
Ann Intern Med. 1989 Mar 1;110(5):365-8. doi: 10.7326/0003-4819-110-5-365.
4
Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection.人类免疫缺陷病毒感染患者血小板减少机制的动力学研究。
N Engl J Med. 1992 Dec 17;327(25):1779-84. doi: 10.1056/NEJM199212173272503.
5
Treatment of human immunodeficiency virus-related thrombocytopenia with zidovudine.齐多夫定治疗人类免疫缺陷病毒相关血小板减少症
JAMA. 1988 Nov 25;260(20):3045-8. doi: 10.1001/jama.260.20.3045.
6
Thrombocytopenic purpura as first manifestation of human immunodeficiency virus type I (HIV-1) infection.血小板减少性紫癜作为I型人类免疫缺陷病毒(HIV-1)感染的首发表现。
Neth J Med. 1990 Aug;37(1-2):63-8.
7
Interferon-alpha is effective in the treatment of HIV-1-related, severe, zidovudine-resistant thrombocytopenia. A prospective, placebo-controlled, double-blind trial.
Ann Intern Med. 1994 Sep 15;121(6):423-9. doi: 10.7326/0003-4819-121-6-199409150-00005.
8
HIV-seropositive thrombocytopenia: the action of zidovudine.HIV血清阳性血小板减少症:齐多夫定的作用
AIDS. 1991 Nov;5(11):1351-6.
9
Comparison of two dose regimens of zidovudine in an open, randomized, multicentre study for severe HIV-related thrombocytopenia.在一项针对严重HIV相关血小板减少症的开放性、随机、多中心研究中,齐多夫定两种剂量方案的比较。
AIDS. 1993 Feb;7(2):209-12. doi: 10.1097/00002030-199302000-00008.
10
Zidovudine for the treatment of thrombocytopenia associated with human immunodeficiency virus (HIV). A prospective study. The Swiss Group for Clinical Studies on the Acquired Immunodeficiency Syndrome (AIDS).齐多夫定治疗与人类免疫缺陷病毒(HIV)相关的血小板减少症。一项前瞻性研究。瑞士获得性免疫缺陷综合征(AIDS)临床研究组。
Ann Intern Med. 1988 Nov 1;109(9):718-21. doi: 10.7326/0003-4819-109-9-718.

引用本文的文献

1
Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.齐多夫定。其药效学和药代动力学特性以及治疗效果的最新情况。
Drugs. 1993 Sep;46(3):515-578. doi: 10.2165/00003495-199346030-00010.